Switch to
More onapp

How to use scorecard? Learn more

Global Longlife Hospital and Research Ltd

GLHRL
Health CareHealth Care Facilities
SmallcapWith a market cap of ₹34 cr, stock is ranked 3,761
High RiskStock is 5.05x as volatile as Nifty
32.953.66 (-10.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CareHealth Care Facilities
SmallcapWith a market cap of ₹34 cr, stock is ranked 3,761
High RiskStock is 5.05x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
1.33
Dividend YieldDiv. Yield
Sector PESector PE
49.79
Sector PBSector PB
6.29
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Global Longlife Hospital and Research Limited is a multispecialty hospital operator. The Company's medical services include oncology, ophthalmology, allergy & immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes & endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery and ear, nose and throat (ENT). Its radiology services include mammography, CT scan, X-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.

Financial TrendFinancial statements 

202120222023202432.7633.0523.7413.572.053.581.83-2.20
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting 
Announced OnOct 28, 2024

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

Board Meeting 
Announced OnOct 28, 2024

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

Result 
Announced OnOct 28, 2024

Global Longlife Hospital and Research Ltd - 543520 - Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

Global Longlife Hospital and Research Ltd - 543520 - Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download

See all events